The company reported $0.22 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.22, FiscalAI reports. Bioventus Stock PerformanceBVS traded up $1.70 during trading on Wednesday, reaching $15.12. Fifth Third Bancorp bought a new position in shares of Bioventus during the first quarter valued at $1,478,000. Wesbanco Bank Inc. acquired a new stake in shares of Bioventus in the 1st quarter valued at $895,000. Weiss Ratings reiterated a “hold (c)” rating on shares of Bioventus in a research note on Tuesday, June 2nd.